NASDAQ:AQB

AquaBounty Technologies Stock Forecast, Price & News

$11.07

+0.33 (+3.07 %)

(As of 01/28/2021 10:28 AM ET)

Add

Compare

Today's Range

$10.06

Now: $11.07▼

$11.07

50-Day Range

$8.40

MA: $9.80▼

$12.20

52-Week Range

$1.52

Now: $11.07▼

$13.32

Volume14,684 shs

Average Volume2.91 million shs

Market Capitalization$614.35 million

P/E RatioN/A

Dividend YieldN/A

Beta1.27

AquaBounty Technologies, Inc. develops and markets products to enhance productivity in land-based aquaculture. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was founded in 1991 and is headquartered in Maynard, Massachusetts.

MarketRank^™

Overall MarketRank^™

1.43 out of 5 stars

Medical Sector

515th out of 1,926 stocks

Fishing, Hunting & Trapping Industry

1st out of 5 stocks

1.5 Analyst's Opinion

Consensus Rating
AquaBounty Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $5.83, AquaBounty Technologies has a forecasted downside of 47.0% from its current price of $11.00.
Amount of Analyst Coverage
AquaBounty Technologies has only been the subject of 1 research reports in the past 90 days.

2.5 Community Rank

Outperform Votes
AquaBounty Technologies has received 177 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
AquaBounty Technologies has received 183 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
AquaBounty Technologies has received 50.83% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about AquaBounty Technologies and other stocks. Vote “Outperform” if you believe AQB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AQB will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
AquaBounty Technologies does not currently pay a dividend.
Dividend Growth
AquaBounty Technologies does not have a long track record of dividend growth.

2.5 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, AquaBounty Technologies insiders have bought more of their company's stock than they have sold. Specifically, they have bought $65,000.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
42.30% of the stock of AquaBounty Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
60.01% of the stock of AquaBounty Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6 Earnings and Valuation

Earnings Growth
Earnings for AquaBounty Technologies are expected to grow in the coming year, from ($0.39) to ($0.19) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of AquaBounty Technologies is -23.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of AquaBounty Technologies is -23.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
AquaBounty Technologies has a P/B Ratio of 10.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Fishing, hunting & trapping

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:AQB

Previous Symbol

CUSIPN/A

CIK1603978

Webwww.aquabounty.com

Phone978-648-6000

Employees71

Year FoundedN/A

Debt

Debt-to-Equity Ratio0.14

Current Ratio18.33

Quick Ratio17.10

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$190,000.00

Price / Sales3,233.43

Cash FlowN/A

Price / Cash FlowN/A

Book Value$1.10 per share

Price / Book10.06

Profitability

EPS (Most Recent Fiscal Year)($0.66)

Net Income$-13,230,000.00

Net Margins-11,050.81%

Return on Equity-36.77%

Return on Assets-30.50%

Miscellaneous

Outstanding Shares55,497,000

Market Cap$614.35 million

Next Earnings Date3/9/2021 (Estimated)

OptionableNot Optionable

$11.07

+0.33 (+3.07 %)

(As of 01/28/2021 10:28 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive AQB News and Ratings via Email

Sign-up to receive the latest news and ratings for AQB and its competitors with MarketBeat's FREE daily newsletter.

AquaBounty Technologies (NASDAQ:AQB) Frequently Asked Questions

How has AquaBounty Technologies' stock been impacted by Coronavirus (COVID-19)?

AquaBounty Technologies' stock was trading at $1.85 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AQB stock has increased by 480.5% and is now trading at $10.74.
View which stocks have been most impacted by COVID-19.

Is AquaBounty Technologies a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AquaBounty Technologies in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AquaBounty Technologies stock.
View analyst ratings for AquaBounty Technologies or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than AquaBounty Technologies?

Wall Street analysts have given AquaBounty Technologies a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but AquaBounty Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is AquaBounty Technologies' next earnings date?

AquaBounty Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, March 9th 2021.
View our earnings forecast for AquaBounty Technologies.

How were AquaBounty Technologies' earnings last quarter?

AquaBounty Technologies, Inc. (NASDAQ:AQB) announced its earnings results on Tuesday, November, 3rd. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.08) by $0.01. The business had revenue of $0.07 million for the quarter, compared to analyst estimates of $1.79 million. AquaBounty Technologies had a negative trailing twelve-month return on equity of 36.77% and a negative net margin of 11,050.81%.
View AquaBounty Technologies' earnings history.

What price target have analysts set for AQB?

3 analysts have issued twelve-month price targets for AquaBounty Technologies' stock. Their forecasts range from $3.50 to $9.00. On average, they anticipate AquaBounty Technologies' share price to reach $5.83 in the next twelve months. This suggests that the stock has a possible downside of 45.7%.
View analysts' price targets for AquaBounty Technologies or view Wall Street analyst' top-rated stocks.

Who are some of AquaBounty Technologies' key competitors?

Some companies that are related to AquaBounty Technologies include Inovio Pharmaceuticals (INO), UDG Healthcare (UDHCF), ModivCare (MODV), Arcus Biosciences (RCUS), ADC Therapeutics (ADCT), Avanos Medical (AVNS), Health Catalyst (HCAT), Eargo (EAR), Outset Medical (OM), Axonics Modulation Technologies (AXNX), NantKwest (NK), Fulgent Genetics (FLGT), Seres Therapeutics (MCRB), UDG Healthcare plc (UDG.L) (UDG) and Myovant Sciences (MYOV).
View all of AQB's competitors.

What other stocks do shareholders of AquaBounty Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AquaBounty Technologies investors own include Celldex Therapeutics (CLDX), Precigen (PGEN), ZIOPHARM Oncology (ZIOP), AbbVie (ABBV), Ocular Therapeutix (OCUL), AT&T (T), Aurora Cannabis (ACB), Allena Pharmaceuticals (ALNA), Evofem Biosciences (EVFM) and Rigel Pharmaceuticals (RIGL).

Who are AquaBounty Technologies' key executives?

AquaBounty Technologies' management team includes the following people:

Ms. Sylvia A. Wulf, CEO, Pres & Exec. Director (Age 63, Pay $383.17k)
Mr. David A. Frank, CFO & Treasurer (Age 61, Pay $282.8k)
Dr. Alejandro Rojas, Chief Operating Officer of AquaBounty Farms (Age 59, Pay $234.1k)
Dr. Mark Walton, Chief Technology Officer
Ms. Angela M. Olsen J.D., Gen. Counsel & Corp. Sec. (Age 52)
Dave Conley, Director of Communications
Mr. David F. Melbourne Jr., Chief Commercial Officer
Mr. Louis H. Barnett, Financial Advisor

What is AquaBounty Technologies' stock symbol?

AquaBounty Technologies trades on the NASDAQ under the ticker symbol "AQB."

Who are AquaBounty Technologies' major shareholders?

AquaBounty Technologies' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Epiq Partners LLC (1.46%), Winthrop Advisory Group LLC (0.02%) and IFP Advisors Inc (0.01%). Company insiders that own AquaBounty Technologies stock include David A Frank, Randal J Kirk, Richard L Huber and Rick L Sterling.
View institutional ownership trends for AquaBounty Technologies.

Which institutional investors are selling AquaBounty Technologies stock?

AQB stock was sold by a variety of institutional investors in the last quarter, including Epiq Partners LLC, and Winthrop Advisory Group LLC.
View insider buying and selling activity for AquaBounty Technologies or view top insider-selling stocks.

Which institutional investors are buying AquaBounty Technologies stock?

AQB stock was bought by a variety of institutional investors in the last quarter, including IFP Advisors Inc. Company insiders that have bought AquaBounty Technologies stock in the last two years include David A Frank, Randal J Kirk, Richard L Huber, and Rick L Sterling.
View insider buying and selling activity for AquaBounty Technologies or or view top insider-buying stocks.

How do I buy shares of AquaBounty Technologies?

Shares of AQB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AquaBounty Technologies' stock price today?

One share of AQB stock can currently be purchased for approximately $10.74.

How big of a company is AquaBounty Technologies?

AquaBounty Technologies has a market capitalization of $596.04 million and generates $190,000.00 in revenue each year. The company earns $-13,230,000.00 in net income (profit) each year or ($0.66) on an earnings per share basis. AquaBounty Technologies employs 71 workers across the globe.

What is AquaBounty Technologies' official website?

The official website for AquaBounty Technologies is www.aquabounty.com.

How can I contact AquaBounty Technologies?

AquaBounty Technologies' mailing address is 2 MILL & MAIN PLACE SUITE 395, MAYNARD MA, 01754. The company can be reached via phone at 978-648-6000 or via email at [email protected]

This page was last updated on 1/28/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here